Medication Therapy Management (MTM)

AMCP 2024 AAO report feature

A Managed Care “North Star:” AMCP’s AAO Report Helps Illustrate How Managed Care Tools Maximize Patient Outcomes

In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.
Medication Therapy Management (MTM), Prior Authorization/Electronic Prior Authorization (ePA), Step Therapy, Managed Care Practice Issues
JMCP Cover Image

Is It Time to Replace The Star Ratings Adherence Measures?

Measures of medication adherence to noninsulin diabetes medications (NIDM), statins, and renin angiotensin system antagonists (RASA) have been continuously used in the star ratings program since 2012. Adherence to these treatments is undoubtedly important. However, the consistent use of these measures in the star ratings program over time has limitations.